---
figid: PMC6951458__CTS-13-57-g001
figtitle: Mnk 1/2 signaling
organisms:
- NA
pmcid: PMC6951458
filename: CTS-13-57-g001.jpg
figlink: pmc/articles/PMC6951458/figure/cts12678-fig-0001/
number: F1
caption: Schematic diagram of Mnk 1/2 signaling. The extracellular signal‐regulated
  kinase and p38 mitogen‐activated protein kinase pathways phosphorylate and activate
  Mnk 1/2 kinases. Mnk 1/2 kinases phosphorylate the eukaryotic translation initiation
  factor 4E, which initiates protein translation and promotes tumor development. Mnk
  1/2 kinases affect other less explored targets. The PI3K/Akt/mTOR/S6Ks pathway may
  also phosphorylate the eIF4E. P, phosphorylate.
papertitle: First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC‐206, an
  Oral Mnk 1/2 Kinase Inhibitor Oncology Drug.
reftext: Vincenzo Teneggi, et al. Clin Transl Sci. 2020 Jan;13(1):57-66.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8730955
figid_alias: PMC6951458__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6951458__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6951458__CTS-13-57-g001.html
  '@type': Dataset
  description: Schematic diagram of Mnk 1/2 signaling. The extracellular signal‐regulated
    kinase and p38 mitogen‐activated protein kinase pathways phosphorylate and activate
    Mnk 1/2 kinases. Mnk 1/2 kinases phosphorylate the eukaryotic translation initiation
    factor 4E, which initiates protein translation and promotes tumor development.
    Mnk 1/2 kinases affect other less explored targets. The PI3K/Akt/mTOR/S6Ks pathway
    may also phosphorylate the eIF4E. P, phosphorylate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - pk
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - p38a
  - p38b
  - Akt
  - Crtc
  - Erk7
  - rl
  - lok
  - eIF4E1
  - eIF4E7
  - eIF4E4
  - eIF4E5
  - eIF4E3
  - eIF4E6
  - eIF4EHP
  - Hrb87F
  - egr
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAPK14
  - MAPK11
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - MKNK1
  - MKNK2
  - ATP7A
  - EIF4E
  - EIF4E2
  - EIF4E3
  - PLA2G4A
  - KAT5
  - SPRY2
  - HNRNPA1
  - TNF
  - Tyrosine
  - Arachidonate
  - Cancers
  - metabolic diseases
---
